Compare DRTS & PNTG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | DRTS | PNTG |
|---|---|---|
| Founded | 2015 | 2019 |
| Country | Israel | United States |
| Employees | N/A | N/A |
| Industry | Medical/Dental Instruments | Medical/Nursing Services |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.3B | 1.5B |
| IPO Year | 2021 | 2019 |
| Metric | DRTS | PNTG |
|---|---|---|
| Price | $14.44 | $40.60 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 5 | 7 |
| Target Price | $17.80 | ★ $46.67 |
| AVG Volume (30 Days) | ★ 441.6K | 343.5K |
| Earning Date | 11-19-2026 | 11-04-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 20.00 |
| EPS | N/A | ★ 0.49 |
| Revenue | N/A | ★ $947,705,000.00 |
| Revenue This Year | N/A | $24.90 |
| Revenue Next Year | $1,235.59 | $7.79 |
| P/E Ratio | ★ N/A | $82.43 |
| Revenue Growth | N/A | ★ 36.31 |
| 52 Week Low | $3.43 | $22.26 |
| 52 Week High | $15.79 | $42.74 |
| Indicator | DRTS | PNTG |
|---|---|---|
| Relative Strength Index (RSI) | 47.85 | 55.61 |
| Support Level | $13.73 | $37.75 |
| Resistance Level | $15.01 | $42.66 |
| Average True Range (ATR) | 0.58 | 1.55 |
| MACD | -0.10 | -0.00 |
| Stochastic Oscillator | 9.46 | 54.05 |
Alpha Tau Medical Ltd is a clinical-stage oncology therapeutics company focused on harnessing the innate relative biological effectiveness and short range of alpha particles for use as a localized radiation therapy for solid tumors. Its proprietary Alpha DaRT technology is designed to utilize the specific therapeutic properties of alpha particles while aiming to overcome, and even harness for potential benefit, the traditional shortcomings of alpha radiation's limited range. The company has active clinical programs targeting a range of different tumor types, such as head and neck cancer, pancreatic cancer, brain cancer, liver metastases, lung cancer, and prostate cancer. Geographically, it operates in Israel, United States, and Japan with the majority of the revenue generated from Israel.
Pennant Group Inc is engaged in providing healthcare services to patients of all ages, including the growing senior population, in the United States. It operates in multiple lines of business including home health, hospice, and senior living which includes the company's assisted living, independent living, and memory care communities across Arizona, California, Colorado, Idaho, Montana, Nevada, Oklahoma, Oregon, Texas, Utah, Washington, Wisconsin, and Wyoming. It operates in two segments; home health and hospice services and senior living services. The company generates majority of its revenue from home health and hospice services segment, which includes its home health, hospice and home care businesses.